Drug-Drug Interaction - 3 Arm - Carboplatin/Paclitaxel, Dacarbazine

Clinical trial NCT00796991 · COMPLETED

Trial details

NCT number: NCT00796991
Sponsor: Bristol-Myers Squibb
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Melanoma

Start date: 2009-02-01
Primary completion: 2009-11-01
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.